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GRAPHICAL ABSTRACT 
 
 
Abstract The condensation of do-, hexa-, octadecan-1-amines with bromo- and 
nitrobenzaldehydes yielded a series of Schiff bases in good yields. Subsequent reaction of these 
compounds with dioctylphosphine oxide yielded phosphorylated azomethines and some were 
characterized using X-ray crystallography. The structure of the isolated compounds was 
determined by IR and NMR spectroscopy, elemental analysis, and their thermal stability was 
studied by simultaneous thermogravimetry and differential scanning calorimetry. All of the 
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synthesized compounds were tested for their antibacterial and anti-Candida activity. A number 
of the compounds exhibited antimicrobial activity comparable to that of the commercially 
available drugs, ciprofloxacin and clotrimazole. 
 
Keywords Phosphorylated Schiff bases; organophosphorus compounds; antimicrobial activity 
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INTRODUCTION 
 Azomethines and their phosphorylated products with aliphatic long-chain, due to their unique 
reactivity, are important in the construction of various multifunctional compounds with a broad 
spectrum of biological activity
1-6
. However, literature survey has indicated that all obtained by us 
phosphorylated Schiff bases have not been synthesized and their biological activities have not 
been tested.  
RESULTS AND DISCUSSION 
 Phosphorylated Schiff bases 5-8 of saturated benzaldehydes were synthesized by the 
reaction of dioctylphosphine oxide with Schiff bases 1-4 derived by the condensation of hexa-, 
octadecan-1-amines with bromo- and nitrobenzaldehydes as shown in scheme 1 respectively.  
We have found that the amination of 4-bromo- and 4-nitrobenzaldehydes with long-chain 
aliphatic amines ie hexa- and octadecan-1-amines in ratios in ethanol–diethyl ether (1:3) at room 
temperature under vigorous stirring gave products of condensation – azomethines 1-4. Heating in 
ethanol these compounds leads to the formation of products 5-8. The structure of the isolated 
compounds was determined by IR and NMR spectroscopy, elemental and X-ray analysis; their 
thermal stability was studied by simultaneous thermogravimetry and differential scanning 
calorimetry. All of the synthesized compounds were fully characterized by physical data in Table 
1. 
The structure of compound 3 was confirmed by X-ray analysis (Fig. 1.). 
 
The antibacterial and antifungal activity of a series of azomethines (1-4) and their 
phosphorylated products (5-8) were investigated in vitro against several pathogenic 
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representative Gram-negative bacteria (Pseudomonas aeruginoza ATCC 27853 and Escherichia 
coli ATCC 25922), Gram-positive bacteria (Staphylococcus aureus ATCC 29213 and Bacillus 
cereus ATCC 11778), and pathogenic fungi Candida albicans ATCC 885-653. The results were 
summarized in Table 2.  
Cup-plate Agar method was used for evaluation of antibacterial activity. The nutrient 
agar medium is used. The medium with bacteria was poured into sterilized Petri dishes under 
aseptic conditions. Standard drugs were Chlorhexidine (50 µg/0.1 mL) and test compounds at 
concentration of 50 µg/0.1 mL. Solvent used was mixture of water and isopropanol at different 
ratios (1:10). Plates were incubated at 37
o
C for 24 hours. The antifungal activity was carried out 
by using cup-plate method using Sabouraud’s agar medium. The standard drug used was 
Griseofulvin (50 µg/0.1 mL) and the test compounds at concentration of 50 µg/0.1 mL by using 
of the mixture of solvents–ethanol – water at different ratios (1:10). After incubation the average 
of inhibition was recorded in mm. 
 
The synthesized compounds exhibited moderate antimicrobial activities in vitro. 
Especially, compounds 1 and 3 with hexadecylalkyl chain showed the most potent antibacterial 
and antifungal activities as compared to Chlorhexidine and Griseofulvin as reference drugs, 
against Staphylococcus aureus, Escherichia coli, Bacillus cereus, Pseudomonas aeruginoza and 
Candida albicans. 
CONCLUSIONS 
In conclusion, new Schiff bases and their phosphorylated compounds were synthesized 
and their structures were determined by IR, NMR, TG-DSC and X-ray analyses. The 
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antimicrobial activity was measured. We have also reported the first crystal structures of these 
compounds.  
EXPERIMENTAL 
All chemicals purchased from Sigma-Aldrich were reagent grade and used without 
purification. IR spectra were taken on a spectrophotometer Specord 251R in the range 400-3700 
cm
-1
 from mulls in mineral oil between KBr plates. 
31
P NMR spectra were registered on a 
spectrometer Bruker Avance-400. Chemical shifts were determined with respect to external 
reference, 85% H3PO4. The purity and thermal stability of crystal compounds were determined 
by simultaneous TG/DSC analysis on a NETZSCH STA 449C instrument (temperature range 20-
400
o
C, heating rate 10 deg/min, argon atmosphere). 
General procedure for the synthesis of phosphorylated azomethines - N-(4-bromo- or 
nitrobenzylidene)alkyl-1-amines 1-4. 
A series of Schiff bases (1-4) were synthesized by the condensation of do-, hexa-, 
octadecan-1-amines with bromo- and nitrobenzaldehydes in good yields in ethanol. The reaction 
mixture was left overnight at room temperature, wherein the crystals of the product were 
precipitated out. The crystals were collected by suction filtration, washed with EtOH and dried. 
General procedure for the synthesis of phosphorylated azomethines - (R)-((4-bromo- or 
nitrophenyl)(alkylamino)methyl)dioctylphosphine oxides 5-8.  
Phosphorylated Schiff bases (5-8) were synthesized by the reaction of dioctylphosphine 
with Schiff bases (1-4) in ethanol. A suspension was refluxed for 16 h. The reaction mixture was 
left overnight at room temperature, wherein the crystals of the product were precipitated out. The 
crystals were collected by suction filtration, washed with EtOH and dried. 
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Supplementary Materials 
X-ray Structure Determination (XRD) 
A data set for single crystal of C25H42N2O2 4 was collected on a Bruker AXS Kappa 
APEX Duo diffractometer with graphite-monochromated Cu K radiation (λ= 1.54178 Å) at T = 
198(2) K. Crystal size 0.054 mm x 0.149 mm x 0.494 mm. Programs used: data collection 
APEX2
7
, data reduction SAINT
8
, structure solution SHELXS97
9
, structure refinement by full-
matrix least-squares against F
2
 using SHELXL-97
9
.  
Crystal data for C25H42N2O2, M = 402.6 g/mol, monoclinic, space group P2(1) (No. 4), Z 
= 4, a = 4.6112(6) b = 80.735(11)c = 6.5786(8) Å, V = 2377.2(5) Å
3
, ρcalc = 1.125 gcm
-3
, 
μ=0.543 mm-1, multi-scan absorption correction was applied using SADABS10, 33313 reflections 
collected (h, k, l), θ range = 1.090 to 52.670, 4949 independent (Rint = 0.0402) and 4690 
observed reflections [I  2 (I)], 523 refined parameters, R = 0.0693, wR2 = 0.2365, max. 
residual electron density 0.269 (-0.312) e Å
-3
. Completeness is low because of the weakly 
diffracting thin plate under Cu-radiation.  
Crystallographic data for the structural analysis of compound 4 has been deposited at the 
Cambridge Crystallographic Data Center (CCDC number 1486043). Copies of the information 
may be obtained free of charge from The Director, CCDC, 12 Union Road, Cambridge CB2 1 
EZ, UK (Fax: + 44-1223-336033; email: deposit@ccdc.cam.ac.uk or www.ccdc.can.ac.uk). 
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Table 1. Physical data for the Schiff bases 1-4 and their corresponding phosphorylated 
compounds 5-8 
Compound Mw 
(g/mol) 
Yield 
(%) 
Empirical 
formula 
Found 
(calc) 
(%) 
   m.p. 
(
o
C) 
C H N P 
1 407.9 82 C23H38BrN 67.53 
(67.66) 
9.41 
(9.32) 
3.57 
(3.43) 
- 44.1 
2 435.9 79 C25H42BrN 69.11 
(68.82) 
9.87 
(9.64) 
3.03 
(3.21) 
- 57.2 
3 374 71 C23H38N2O2 74.07 
(73.80) 
9.87 
(10.16) 
7.77 
(7.49) 
- 69.9 
4 402 78 C25H42N2O2 74.58 
(74.63) 
9.99 
(10.45) 
7.09 
(6.97) 
- 60.8 
5 681.9 77 C39H73BrNOP 69.03 
(68.63) 
11.03 
(10.71) 
2.33 
(2.53) 
4.27 
(4.55) 
oil 
6 709.9 81 C41H77BrNOP 69.76 
(69.31) 
10.97 
(10.85) 
2.03 
(1.97) 
4.03 
(4.37) 
oil 
7 648 76 C39H73N2O3P 72.01 
(72.22) 
11.43 
(11.27) 
4.67 
(4.32) 
4.87 
(4.78) 
oil 
8 676 82 C41H77N2O3P 73.13 
(72.78) 
11.57 
(11.39) 
4.03 
(4.14) 
4.63 
(4.59) 
oil 
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Table 2. Antimicrobial activity (growth inhibition zone, mm) of compounds (c = 50 
µg/0.1 mL) 
Compound Staphylococcus 
aureus 
Escherichia 
coli 
Bacillus 
cereus 
Pseudomonas 
aeruginosa 
Candida 
albicans 
1 28 25 45 30 32 
2 26 21 33 19 30 
3 60 31 48 27 29 
4 28 19 31 17 27 
5 25 17 13 15 29 
6 21 25 13 21 26 
7 23 18 15 13 22 
8 19 17 11 16 24 
Chlorhexidine 16+0.5 15+0.2 10+0.3 8+0.1 19- 
Griseofulvin 0 0 0 0 19+02 
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Figure 1. Geometry of the molecule of crystal 4 - N-(4-nitrobenzylidene)octadecan-1-
amine  
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Scheme 1 
 
